A new Nature Medicine Perspective, “Immune Aging Biomarkers for Clinical Trials,” tackles a question at the heart of HIP’s mission: there’s still no agreed-upon way to measure immune aging. Co-authored by HIP Co-Chief Scientific Officers Shai Shen-Orr and John Tsang, alongside researchers from Stanford, Yale, UConn, University College London, the National Institute on Aging, and others, the…
Decoding the immunome has been science fiction—until now
With deep immune profiling + AI, we can better predict and understand both health and disease. This is the future of medicine.
Explore Our Mission
Meet the scientists and strategists mapping human immune diversity
Meet the scientists and strategists mapping human immune diversity
Say Hello
Strategic Approach
Strategic Approach
Our scientific plan offers an actionable roadmap to understand immune variability across the globe:
Build: Build the MVP tools and platform that become the global standard for deep immunological profiling.
Generate: Generate HIP standardized data and create the models that will quantify and predict immune states.
Facilitate: Accelerate translation of new biomarkers, new druggable targets, and new reference ranges for pharma and clinicians.
Become a HIPster
Become a HIPster
Sign-up for our newsletter to stay up-to-date on the latest HIP developments and track our progress.
Stay Informed
HIP Banbury Series – Cold Spring Harbor, 2025
This series of conversations was recorded at the Banbury Center in November 2025, when HIP convened the world’s leading systems immunologists to advance our mission to decode human immunity for all.